Compliance · State rules

Office-use compounding in West Virginia

Not established — the statute is silent and the operative rule has not been read

USPeptideRx EditorialLast reviewed: August 31, 2026

West Virginia is the one state in this file to which we give no answer, and the honest reason is that the instrument which would decide it has not been read by anyone working on this site. The statute is genuinely silent: the phrase "office use" does not occur anywhere in the material we read. The operative detail lives in the West Virginia Code of State Rules, and the Secretary of State publishes those rules through a search form that returned no rule text to us at all. So this page publishes what the statute does establish — which is more than it first appears — and stops. Do not read the statutory silence as permission: three provisions point the other way, and one of them turns preparing bulk compounds for resale by practitioners into manufacturing, which is a permit offence rather than a practice one.

The governing rule

West Virginia’s office-use position is set by W. Va. Code § 30-5-4 (definitions), with § 30-5-25(b). The text below is quoted verbatim; everything outside a quote block is our summary of it, and the two are kept visually separate on purpose.

W. Va. Code § 30-5-4 — the definition of compounding, including its anticipatory limb

"Compounding" means: (A) The preparation, mixing, assembling, packaging, or labeling of a drug or device: (i) As the result of a practitioner’s prescription drug order or initiative based on the practitioner/patient/pharmacist relationship in the course of professional practice for sale or dispensing; or (ii) For the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing; and (B) The preparation of drugs or devices in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns.

W. Va. Code § 30-5-4 — the closing sentence of the definition of manufacturing

Manufacturing also includes the preparation and promotion of commercially available products from bulk compounds for resale by pharmacies, practitioners, or other persons.

W. Va. Code § 30-5-25(b) — what manufacturing then requires

A person may not manufacture, package or prepare a drug without obtaining a permit from the board.

W. Va. Code § 60A-3-301 — the controlled-substances credential, split by function rather than by drug class

The state Board of Pharmacy shall promulgate rules and charge fees relating to the registration and control of the manufacture and distribution of controlled substances within this state, and each department, board, or agency of this state which licenses or registers practitioners authorized to dispense any controlled substance shall promulgate rules and charge fees relating to the registration and control of the dispensing of controlled substances within this state by those practitioners licensed or registered by such department, board, or agency.

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

Why this page has no verdict, stated plainlyHigh confidence: West Virginia’s pharmacy statute says nothing about office use in either direction. The rules that would say something are the Code of State Rules, and the Secretary of State publishes them through a search interface that served us a query form rather than rule text — over a megabyte of page containing thousands of dropdown options, dozens of links and not one section of a rule. The Board’s own pages cite two of those rules by number, and we could not reach either. So the answer is unread, not absent, and this page says that instead of guessing.
Do not read the silence as permission — the manufacturing definition is the reasonHigh confidence: The most load-bearing sentence in West Virginia’s pharmacy statute is inside a definition, and it is easy to miss because nothing in the operative sections repeats it. The definition of manufacturing ends by including the preparation and promotion of commercially available products from bulk compounds for resale by pharmacies, practitioners or other persons. Paired with the prohibition on manufacturing, packaging or preparing a drug without a board permit, that is a real constraint sitting where a reader skimming for a compounding rule would never look.
The compounding definition does have an anticipatory limb, and it is not patient-tetheredHigh confidence: Limb (B) reaches the preparation of drugs or devices in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns, and it carries no patient-specific requirement of its own. That is the strongest textual point available to anyone arguing West Virginia is permissive. It is not enough to support a verdict on its own, and this page does not treat it as one.
The five per cent clause here does not reach practitioners at allHigh confidence: West Virginia carries a five per cent provision, and it is narrower than most in this file. It sits inside the definition of wholesale distribution, treats transfers of prescription drugs by a retail pharmacy to another retail pharmacy to alleviate a temporary shortage as made for emergency medical reasons, and caps them at five per cent of the total prescription drug sales revenue of either the transferor or transferee pharmacy in any twelve consecutive month period. It runs pharmacy to pharmacy. It does not reach a practitioner, and it is not authority for supplying one.
The Board publishes no outsourcing facility licence class under any nameHigh confidence: The Board of Pharmacy’s own facilities overview enumerates its licence types: in-state pharmacies, an in-state controlled substance permit, a limited pseudoephedrine distributor, mail order pharmacy, manufacturer, third party logistics provider and wholesale drug distributor. The word "outsourcing" does not appear on it. A reader can check that in ten seconds, which is why it is stated here as a fact about the Board’s published taxonomy rather than as a conclusion about what West Virginia requires.The page carries its own update stamp of 3 April 2018. What an outsourcing facility should actually apply for in West Virginia is a question for the Board.
Two licensure mandates are hidden inside definitionsHigh confidence: The definitions of third-party logistics provider and exclusive distributor each end by requiring that the entity be licensed as a wholesale distributor under the article. A reader who reads the operative licensing sections and skips the definitions will miss both obligations entirely.
A telehealth condition is buried in a definition tooHigh confidence: West Virginia defines a valid patient-practitioner relationship to require a medical complaint, a medical history, a face-to-face physical examination adequate to establish the complaint or telemedicine practice approved by the appropriate practitioner board, and a logical connection between them. It is a definition rather than a prohibition, which is exactly why it gets missed.
Sterile compounding is not addressed in the statute at allHigh confidence: The word does not appear anywhere in the statutory material we read. Whatever West Virginia requires of sterile compounding is in the unread rules, so no sterile-versus-non sterile split can be reported here in either direction.

West Virginia at a glance

West Virginia office-use compounding summary, reviewed 2026-08-31
Human office use	Not established — statute silent, and the operative rule is beyond what we have read
Sterile preparations	Not established — the word does not appear in the statute
Quantity cap	None in statute; the five per cent clause runs pharmacy to pharmacy only
Mandatory label legend	Not established — dispensing label rules sit in the unread rules
Board reporting	Not established
Last change	Statutory framework last substantially revised 2012–2013
Governing rule	W. Va. Code § 30-5-4 (definitions), with § 30-5-25(b)

Receiving 503B office stock in West Virginia

West Virginia splits the controlled-substances credential by FUNCTION rather than by drug class, and the split lands exactly on the side a prescriber cares about. Checking the pharmacy board here produces the wrong answer for a receiving practice.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What West Virginia asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inLow confidence: Not established under that name. The Board publishes no outsourcing facility class; its nearest categories are wholesale drug distributor, at $750 a year, and manufacturer, and its own guidance routes non-resident manufacturers to the manufacturer application. Which of those a 503B should hold is a question for the Board rather than something this page can answer from the statute.
Does your practice need a permit?Medium confidence: For controlled substances there is a registration, and the annual fee for a hospital or clinic is $15. Registration is per site: a separate registration is required at each principal place of business or professional practice. Whether a practice needs anything further to hold non-controlled compounded stock is not established, for the same reason the verdict is not.
Administer vs dispenseHigh confidence: This distinction does more work in West Virginia than almost anywhere, because the controlled-substances statute allocates regulatory authority by it rather than by drug class. Manufacture and distribution go to the Board of Pharmacy; dispensing goes to whichever body licenses the practitioner. So the same clinic can sit under two different regulators for two halves of one supply chain.
Scheduled (controlled) stockHigh confidence: A 503B shipping controlled substances into West Virginia registers with the Board of Pharmacy, because that is the distribution side. The receiving physician does not: a practitioner’s dispensing registration runs through the board that licenses the practitioner — the Board of Medicine or the Board of Nursing rather than the Board of Pharmacy. Most states on this site put both on one desk; Alabama and Oklahoma are the other two that do not, and each sends the practitioner somewhere different again.

How to check a facility’s credential before you order is set out in how to place an office-use order.

The federal layer still applies

Whatever West Virginia law allows, federal law applies on top of it and is not satisfied by state permission. 21 U.S.C. § 353a conditions the federal compounding exemptions on a drug being compounded for an identified individual patient on receipt of a valid prescription order. A state rule cannot create a federal safe harbour, and several state rules say so in their own text. The separate federal pathway for non-patient-specific office stock is the 503B outsourcing facility — the differences are set out in 503A vs 503B.

For how West Virginia compares with the other states reviewed, see the state-by-state comparison.

What this page does not establish

This page does not state whether West Virginia permits, prohibits or conditions office use — the position is not established here, because we have not read the instrument that decides it. The operative rules are the West Virginia Code of State Rules, title 15, and reading them is the single most valuable thing anyone could do to improve this page.
Do not convert that admission into a permission. The statutory silence sits beside a definition of manufacturing that reaches preparing bulk compounds for resale by practitioners, a requirement of a board permit to manufacture or prepare a drug, and a licence trigger for pharmacy distribution. Those point away from an unregulated reading, not toward one.
One warning if you go looking for the rules yourself. The Secretary of State publishes them behind a search form, and the page that form sits on is roughly 1.8 megabytes of dropdown options with no rule text in it at all — so size is no signal that you have found anything. A separate attempt to fetch a rule document returned a large file with no readable text in it, and we could not establish what it was, so we have not used it and do not cite it.
The practitioner-side authority — what a West Virginia prescriber’s own licensing board permits — is beyond the scope of this page, and in this state that matters more than elsewhere, because the controlled-substances statute puts the dispensing question on that board rather than on the pharmacy board.
We searched no case law, attorney-general opinions or declaratory rulings for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.